_id
69130b8fccc777a4e85d7c9a
Ticker
KRMKF
Name
Kromek Group plc
Exchange
PINK
Address
NETPark, Sedgefield, United Kingdom, TS21 3FD
Country
USA
Sector
Technology
Industry
Scientific & Technical Instruments
Currency
USD
Website
https://www.kromek.com
Description
Kromek Group plc, together with its subsidiaries, develops, manufactures, and sells radiation detection components and bio-detection technology solutions for the advanced imaging, CBRN detection, and biological threat detection markets. It offers civil nuclear radiation detection products, which include gamma radiation and neutron detectors, high-specification, high-resolution devices, components, and software for nuclear detection problems, as well as offers a range of radiation detectors that use cadmium zinc telluride (CZT) or scintillator technology for gamma-ray and neutron detection. The company also provides advanced imaging products, including CZT gamma detectors for SPECT imaging, CZT bone mineral densitometry detectors, D-Matrix gamma ray imager, and photon-counting spectral CT systems. In addition, it offers products and components for the security and defence markets, including UAV radiation mapping drones, alpha beta probes, radiation detectors, gamma and neutron detectors, D5 RIID, backpack with radiation detection, static node, tactical deployment detector charging station, and vehicle mounted radiation detector, as well as a range of gamma spectroscopy software that enables specialized analysis of samples. Further, the company provides CZT imaging research development platforms, such as the DMatrix and the EV3500 scalable x-ray CZT linear array for laboratory and research imaging; and engages in the scientific research and development activities. It sells its products through distributors, OEMs, and direct sales. The company has operations in the United Kingdom, North America, Asia, Europe, and internationally. The company was founded in 2003 and is headquartered in Sedgefield, the United Kingdom.
Last Close
0.1174
Volume
-
Current Price
0.1174
Change
2.6086956521739033
Last Updated
2026-01-04T16:11:27.692Z
Image
-
Ipo Date
-
Market Cap
76908368
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2022-10-31
Revenue
-
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
-
Operating Income
-
Interest Expense
-
Pretax Income
-
Net Income
-
Eps
-
Dividends Per Share
-
Shares Outstanding
655096840
Income Tax Expense
-300500
EBITDA
-
Operating Margin
-
Total Other Income Expense Net
-
Cash
956000
Short Term Investments
-
Receivables
7041000
Inventories
10866000
Total Current Assets
18863000
Property Plant Equipment
15059000
Total Assets
65736000
Payables
5986000
Short Term Debt
-
Long Term Debt
3565000
Total Liabilities
21233000
Equity
44503000
Bs_currency_symbol
USD
Depreciation
1213500
Change In Working Capital
-
Cash From Operations
-2013000
Capital Expenditures
93000
Cash From Investing
-1424000
Cash From Financing
1060000
Net Change In Cash
-2062500
Cf_currency_symbol
USD
PE
11.74
PB
1.1392356395748602
ROE
-
ROA
-
FCF
-2106000
Fcf Percent
-
Piotroski FScore
0
Health Score
60
Deep Value Investing Score
6
Defensive Investing Score
6
Dividend Investing Score
1.5
Economic Moat Investing Score
1.5
Garp Investing Score
1.5
Growth Investing Score
0
Momentum Investing Score
0.5
Net Net Investing Score
2.5
Quality Investing Score
2
Value Investing Score
7.5
Quarters > 0 > quarter
2022-10-31
Quarters > 0 > income Statement > revenue
-
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
-
Quarters > 0 > income Statement > operating Income
-
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-
Quarters > 0 > income Statement > net Income
-
Quarters > 0 > income Statement > eps
-
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
431851820
Quarters > 0 > income Statement > income Tax Expense
-300500
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
956000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
7041000
Quarters > 0 > balance Sheet > inventories
10866000
Quarters > 0 > balance Sheet > total Current Assets
18863000
Quarters > 0 > balance Sheet > property Plant Equipment
15059000
Quarters > 0 > balance Sheet > total Assets
65736000
Quarters > 0 > balance Sheet > payables
5986000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
3565000
Quarters > 0 > balance Sheet > total Liabilities
21233000
Quarters > 0 > balance Sheet > equity
44503000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-2535000
Quarters > 0 > cash Flow > depreciation
1213500
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-2013000
Quarters > 0 > cash Flow > capital Expenditures
93000
Quarters > 0 > cash Flow > cash From Investing
-1424000
Quarters > 0 > cash Flow > cash From Financing
1060000
Quarters > 0 > cash Flow > net Change In Cash
-2062500
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-
Quarters > 0 > ratios > PB
1.1392356395748602
Quarters > 0 > ratios > ROE
-
Quarters > 0 > ratios > ROA
-
Quarters > 0 > ratios > FCF
-2106000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
60
Quarters > 1 > quarter
2022-07-31
Quarters > 1 > income Statement > revenue
-
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
-
Quarters > 1 > income Statement > operating Income
-
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-
Quarters > 1 > income Statement > net Income
-
Quarters > 1 > income Statement > eps
-
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
-
Quarters > 1 > income Statement > income Tax Expense
-300500
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
-
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
7041000
Quarters > 1 > balance Sheet > inventories
10866000
Quarters > 1 > balance Sheet > total Current Assets
18863000
Quarters > 1 > balance Sheet > property Plant Equipment
15059000
Quarters > 1 > balance Sheet > total Assets
-
Quarters > 1 > balance Sheet > payables
5986000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
12092000
Quarters > 1 > balance Sheet > equity
-
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-2535000
Quarters > 1 > cash Flow > depreciation
1213500
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-2013000
Quarters > 1 > cash Flow > capital Expenditures
93000
Quarters > 1 > cash Flow > cash From Investing
-1424000
Quarters > 1 > cash Flow > cash From Financing
1060000
Quarters > 1 > cash Flow > net Change In Cash
-2062500
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-
Quarters > 1 > ratios > PB
-
Quarters > 1 > ratios > ROE
-
Quarters > 1 > ratios > ROA
-
Quarters > 1 > ratios > FCF
-2106000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
45
Annuals > 0 > quarter
2024-04-30
Annuals > 0 > income Statement > revenue
19403000
Annuals > 0 > income Statement > cost Of Revenue
8693000
Annuals > 0 > income Statement > gross Profit
10710000
Annuals > 0 > income Statement > operating Expenses
21295000
Annuals > 0 > income Statement > operating Income
-1892000
Annuals > 0 > income Statement > interest Expense
1874000
Annuals > 0 > income Statement > pretax Income
-3455000
Annuals > 0 > income Statement > net Income
-3293000
Annuals > 0 > income Statement > eps
-0.005137131345422312
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
641019234
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-9.751069422254291
Annuals > 0 > income Statement > total Other Income Expense Net
-
Annuals > 0 > income Statement > currency_symbol
GBP
Annuals > 0 > balance Sheet > cash
466000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
10152000
Annuals > 0 > balance Sheet > inventories
10295000
Annuals > 0 > balance Sheet > total Current Assets
24116000
Annuals > 0 > balance Sheet > property Plant Equipment
12075000
Annuals > 0 > balance Sheet > total Assets
70192000
Annuals > 0 > balance Sheet > payables
7345000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
526000
Annuals > 0 > balance Sheet > total Liabilities
20838000
Annuals > 0 > balance Sheet > equity
49354000
Annuals > 0 > balance Sheet > currency_symbol
GBP
Annuals > 0 > cash Flow > net Income
-3293000
Annuals > 0 > cash Flow > depreciation
4509000
Annuals > 0 > cash Flow > change In Working Capital
-6917000
Annuals > 0 > cash Flow > cash From Operations
-2802000
Annuals > 0 > cash Flow > capital Expenditures
5042000
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
-
Annuals > 0 > cash Flow > net Change In Cash
-626000
Annuals > 0 > cash Flow > currency_symbol
GBP
Annuals > 0 > ratios > PE
-0.005137131345422312
Annuals > 0 > ratios > PB
1.5248137551485188
Annuals > 0 > ratios > ROE
-6.6722048871418735
Annuals > 0 > ratios > ROA
-4.6914178253932075
Annuals > 0 > ratios > FCF
-7844000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-0.4042673813327836
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-04-30
Annuals > 1 > income Statement > revenue
17309000
Annuals > 1 > income Statement > cost Of Revenue
8374000
Annuals > 1 > income Statement > gross Profit
8935000
Annuals > 1 > income Statement > operating Expenses
23435000
Annuals > 1 > income Statement > operating Income
-6126000
Annuals > 1 > income Statement > interest Expense
1245000
Annuals > 1 > income Statement > pretax Income
-7292000
Annuals > 1 > income Statement > net Income
-6100000
Annuals > 1 > income Statement > eps
-0.014125215450058773
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
431851820
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-1253000
Annuals > 1 > income Statement > operating Margin
-35.391992605003175
Annuals > 1 > income Statement > total Other Income Expense Net
-
Annuals > 1 > income Statement > currency_symbol
GBP
Annuals > 1 > balance Sheet > cash
1097000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
4568000
Annuals > 1 > balance Sheet > inventories
10894000
Annuals > 1 > balance Sheet > total Current Assets
18460000
Annuals > 1 > balance Sheet > property Plant Equipment
13589000
Annuals > 1 > balance Sheet > total Assets
63878000
Annuals > 1 > balance Sheet > payables
7326000
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
568000
Annuals > 1 > balance Sheet > total Liabilities
22354000
Annuals > 1 > balance Sheet > equity
41524000
Annuals > 1 > balance Sheet > currency_symbol
GBP
Annuals > 1 > cash Flow > net Income
-6100000
Annuals > 1 > cash Flow > depreciation
2469000
Annuals > 1 > cash Flow > change In Working Capital
-20000
Annuals > 1 > cash Flow > cash From Operations
197000
Annuals > 1 > cash Flow > capital Expenditures
5273000
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
-
Annuals > 1 > cash Flow > net Change In Cash
-3787000
Annuals > 1 > cash Flow > currency_symbol
GBP
Annuals > 1 > ratios > PE
-0.014125215450058773
Annuals > 1 > ratios > PB
1.2209662765629516
Annuals > 1 > ratios > ROE
-14.690299585781716
Annuals > 1 > ratios > ROA
-9.549453646012712
Annuals > 1 > ratios > FCF
-5076000
Annuals > 1 > ratios > Piotroski FScore
2
Annuals > 1 > ratios > fcf Percent
-0.2932578427407707
Annuals > 1 > health Score
32
Annuals > 2 > quarter
2022-04-30
Annuals > 2 > income Statement > revenue
12055000
Annuals > 2 > income Statement > cost Of Revenue
6419000
Annuals > 2 > income Statement > gross Profit
5636000
Annuals > 2 > income Statement > operating Expenses
19161000
Annuals > 2 > income Statement > operating Income
-7106000
Annuals > 2 > income Statement > interest Expense
582000
Annuals > 2 > income Statement > pretax Income
-6129000
Annuals > 2 > income Statement > net Income
-4918000
Annuals > 2 > income Statement > eps
-0.011388165505473613
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
431851820
Annuals > 2 > income Statement > income Tax Expense
-1211000
Annuals > 2 > income Statement > EBITDA
-1227000
Annuals > 2 > income Statement > operating Margin
-58.94649523019494
Annuals > 2 > income Statement > total Other Income Expense Net
-
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
5081000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
4860000
Annuals > 2 > balance Sheet > inventories
10503000
Annuals > 2 > balance Sheet > total Current Assets
22955000
Annuals > 2 > balance Sheet > property Plant Equipment
14818000
Annuals > 2 > balance Sheet > total Assets
67423000
Annuals > 2 > balance Sheet > payables
7524000
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
749000
Annuals > 2 > balance Sheet > total Liabilities
19987000
Annuals > 2 > balance Sheet > equity
47436000
Annuals > 2 > balance Sheet > currency_symbol
GBP
Annuals > 2 > cash Flow > net Income
-4918000
Annuals > 2 > cash Flow > depreciation
4320000
Annuals > 2 > cash Flow > change In Working Capital
-2345000
Annuals > 2 > cash Flow > cash From Operations
-3530000
Annuals > 2 > cash Flow > capital Expenditures
651000
Annuals > 2 > cash Flow > cash From Investing
-6415000
Annuals > 2 > cash Flow > cash From Financing
-1566000
Annuals > 2 > cash Flow > net Change In Cash
-10521000
Annuals > 2 > cash Flow > currency_symbol
GBP
Annuals > 2 > ratios > PE
-0.011388165505473613
Annuals > 2 > ratios > PB
1.0687959285774518
Annuals > 2 > ratios > ROE
-10.367653259128089
Annuals > 2 > ratios > ROA
-7.294246770389927
Annuals > 2 > ratios > FCF
-4181000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-0.34682704272086273
Annuals > 2 > health Score
34
Annuals > 3 > quarter
2021-04-30
Annuals > 3 > income Statement > revenue
10352000
Annuals > 3 > income Statement > cost Of Revenue
5346000
Annuals > 3 > income Statement > gross Profit
5006000
Annuals > 3 > income Statement > operating Expenses
16189000
Annuals > 3 > income Statement > operating Income
-5837000
Annuals > 3 > income Statement > interest Expense
548000
Annuals > 3 > income Statement > pretax Income
-6331000
Annuals > 3 > income Statement > net Income
-5353000
Annuals > 3 > income Statement > eps
-0.012395455459699117
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
431851820
Annuals > 3 > income Statement > income Tax Expense
-978000
Annuals > 3 > income Statement > EBITDA
-1739000
Annuals > 3 > income Statement > operating Margin
-56.385239567233384
Annuals > 3 > income Statement > total Other Income Expense Net
-
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
15602000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
4979000
Annuals > 3 > balance Sheet > inventories
6202000
Annuals > 3 > balance Sheet > total Current Assets
29463000
Annuals > 3 > balance Sheet > property Plant Equipment
15276000
Annuals > 3 > balance Sheet > total Assets
70158000
Annuals > 3 > balance Sheet > payables
6000000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
2816000
Annuals > 3 > balance Sheet > total Liabilities
20103000
Annuals > 3 > balance Sheet > equity
50055000
Annuals > 3 > balance Sheet > currency_symbol
GBP
Annuals > 3 > cash Flow > net Income
-5353000
Annuals > 3 > cash Flow > depreciation
4044000
Annuals > 3 > cash Flow > change In Working Capital
-791000
Annuals > 3 > cash Flow > cash From Operations
-1309000
Annuals > 3 > cash Flow > capital Expenditures
454000
Annuals > 3 > cash Flow > cash From Investing
-6071000
Annuals > 3 > cash Flow > cash From Financing
14132000
Annuals > 3 > cash Flow > net Change In Cash
6158000
Annuals > 3 > cash Flow > currency_symbol
GBP
Annuals > 3 > ratios > PE
-0.012395455459699117
Annuals > 3 > ratios > PB
1.0128739120567376
Annuals > 3 > ratios > ROE
-10.694236340025972
Annuals > 3 > ratios > ROA
-7.629921035377291
Annuals > 3 > ratios > FCF
-1763000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-0.17030525502318392
Annuals > 3 > health Score
34
Valuation > metrics > PE
11.74
Valuation > metrics > PB
1.1392356395748602
Valuation > final Score
100
Valuation > verdict
Fair
Profitability > final Score
50
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.4771139024335438
Risk > final Score
80
Risk > verdict
Low
Liquidity > metrics > Current Ratio
3.151186100902105
Liquidity > metrics > Quick Ratio
1.3359505512863348
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
0
Prev Valuations > 2
0
Prev Profitabilities > 0
50
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
50
Prev Risks > 1
0
Prev Risks > 2
0
Prev Liquidities > 0
100
Prev Liquidities > 1
0
Prev Liquidities > 2
0
Updated At
2026-01-20T22:06:38.524Z
Earnings History > 0 > period
2025-10-31
Earnings History > 0 > report Date
2026-01-28
Earnings History > 0 > date
2025-10-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Kromek Group plc, together with its subsidiaries, develops, manufactures, and sells radiation detection components and bio-detection technology solutions for the advanced imaging, CBRN detection, and biological threat detection markets. It offers civil nuclear radiation detection products, which include gamma radiation and neutron detectors, high-specification, high-resolution devices, components, and software for nuclear detection problems, as well as offers a range of radiation detectors that use cadmium zinc telluride (CZT) or scintillator technology for gamma-ray and neutron detection. The company also provides advanced imaging products, including CZT gamma detectors for SPECT imaging, CZT bone mineral densitometry detectors, D-Matrix gamma ray imager, and photon-counting spectral CT systems. In addition, it offers products and components for the security and defence markets, including UAV radiation mapping drones, alpha beta probes, radiation detectors, gamma and neutron detectors, D5 RIID, backpack with radiation detection, static node, tactical deployment detector charging station, and vehicle mounted radiation detector, as well as a range of gamma spectroscopy software that enables specialized analysis of samples. Further, the company provides CZT imaging research development platforms, such as the DMatrix and the EV3500 scalable x-ray CZT linear array for laboratory and research imaging; and engages in the scientific research and development activities. It sells its products through distributors, OEMs, and direct sales. The company has operations in the United Kingdom, North America, Asia, Europe, and internationally. The company was founded in 2003 and is headquartered in Sedgefield, the United Kingdom.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2022-10-31)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Debt to Equity
-
High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Kromek Group plc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-10-31
EPS Estimate
—
Date
—
EPS Actual
—
EPS Estimate
—
EPS Difference
—
Surprise Percent
undefined%
(Last Updated 2022-10-31)
(Last Updated 2022-10-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2022-10-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2022-10-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.